Silva Teresa P, Fernandes Tiago G, Nogueira Diogo E S, Rodrigues Carlos A V, Bekman Evguenia P, Hashimura Yas, Jung Sunghoon, Lee Brian, Carmo-Fonseca Maria, Cabral Joaquim M S
iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa; Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa.
iBB - Institute for Bioengineering and Biosciences and Department of Bioengineering, Instituto Superior Técnico, Universidade de Lisboa.
J Vis Exp. 2020 Jun 13(160). doi: 10.3791/61143.
The cerebellum plays a critical role in the maintenance of balance and motor coordination, and a functional defect in different cerebellar neurons can trigger cerebellar dysfunction. Most of the current knowledge about disease-related neuronal phenotypes is based on postmortem tissues, which makes understanding of disease progression and development difficult. Animal models and immortalized cell lines have also been used as models for neurodegenerative disorders. However, they do not fully recapitulate human disease. Human induced pluripotent stem cells (iPSCs) have great potential for disease modeling and provide a valuable source for regenerative approaches. In recent years, the generation of cerebral organoids from patient-derived iPSCs improved the prospects for neurodegenerative disease modeling. However, protocols that produce large numbers of organoids and a high yield of mature neurons in 3D culture systems are lacking. The protocol presented is a new approach for reproducible and scalable generation of human iPSC-derived organoids under chemically-defined conditions using scalable single-use bioreactors, in which organoids acquire cerebellar identity. The generated organoids are characterized by the expression of specific markers at both mRNA and protein level. The analysis of specific groups of proteins allows the detection of different cerebellar cell populations, whose localization is important for the evaluation of organoid structure. Organoid cryosectioning and further immunostaining of organoid slices are used to evaluate the presence of specific cerebellar cell populations and their spatial organization.
小脑在维持平衡和运动协调方面起着关键作用,不同小脑神经元的功能缺陷可引发小脑功能障碍。目前关于疾病相关神经元表型的大多数知识基于死后组织,这使得理解疾病的进展和发展变得困难。动物模型和永生化细胞系也已被用作神经退行性疾病的模型。然而,它们并不能完全重现人类疾病。人类诱导多能干细胞(iPSC)在疾病建模方面具有巨大潜力,并为再生方法提供了宝贵来源。近年来,从患者来源的iPSC生成脑类器官改善了神经退行性疾病建模的前景。然而,缺乏在3D培养系统中产生大量类器官和高产量成熟神经元的方案。所提出的方案是一种在化学限定条件下使用可扩展的一次性生物反应器可重复且可扩展地生成人类iPSC来源类器官的新方法,其中类器官获得小脑特征。所生成的类器官在mRNA和蛋白质水平上均以特定标志物的表达为特征。对特定蛋白质组的分析允许检测不同的小脑细胞群体,其定位对于评估类器官结构很重要。类器官冷冻切片和类器官切片的进一步免疫染色用于评估特定小脑细胞群体的存在及其空间组织。